Hims is expanding beyond telehealth with a push into hormone care, while building out at-home testing and virtual care services. ・Peptides is also seen as the next growth driver, with Bank of America ...

Novo Nordisk will launch its oral Ozempic pill for type 2 diabetes in the U.S. next week, offering competitive pricing and broad pharmacy availability. The move comes as rival Eli Lilly gains momentum ...

Korrie Stevenson had been feeling off for months. She would look at a gorgeous birthday cake or walk outside to a ...

A 'gold standard' trial found that semaglutide helped reduce drinking in people with obesity who sought out treatment for alcohol-use disorder A new study found that taking Novo Nordisk's semaglutide, ...

Eli Lilly's newly launched oral weight-loss drug, Foundayo, was prescribed 5,612 times in the U.S. in the third week after ...

Eli Lilly and Company (NYSE:LLY) is one of the best drug stocks to buy according to analysts. Eli Lilly and Company (NYSE:LLY ...

A majority of GLP-1 lawsuits come from patients who allege that manufacturers have inadequately warned about severe side ...

Americans' voracious appetite for GLP-1 weight loss drugs has the nation on pace to spend more than $1 trillion on ...

The proposal could affect telehealth services that rely on outside facilities to produce the knockoff drugs in bulk.

CNBC’s Fast Money panel recently made a notable pivot on its April 24 episode, arguing that Novo Nordisk (NYSE:NVO | NVO ...